Biomarker analysis from Phase 1/2 study of tusamitamab ravtansine (SAR408701) in patients with advanced non-small cell lung cancer (NSCLC)Anas Gazzah,Joon Sang Lee,Emma Wang,Nils Ternes,Hong Wang,Eric Boitier, AuDe lartigau,Mustapha Chadjaa,Colette Dib, Gaelle Muzard, Sandrine Valence, Anne Remaury, Cintia C. Palu, Anne-Laure BauchetCANCER RESEARCH（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
